MicroRNA expression patterns of CD8+ T cells in acute and chronic brucellosis

Loading...
Thumbnail Image

Date

2016-10-06

Authors

Güvenç, Furkan
Deniz, Günnur

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library Science

Abstract

Although our knowledge about Brucella virulence factors and the host response increase rapidly, the mechanisms of immune evasion by the pathogen and causes of chronic disease are still unknown. Here, we aimed to investigate the immunological factors which belong to CD8+ T cells and their roles in the transition of brucellosis from acute to chronic infection. Using miRNA microarray, more than 2000 miRNAs were screened in CD8+ T cells of patients with acute or chronic brucellosis and healthy controls that were sorted from peripheral blood with flow cytometry and validated through qRT-PCR. Findings were evaluated using GeneSpring GX (Agilent) 13.0 software and KEGG pathway analysis. Expression of two miRNAs were determined to display a significant fold change in chronic group when compared with acute or control groups. Both miRNAs (miR-126-5p and miR-47533p) were decreased (p <0.05 or fold change > 2). These miRNAs have the potential to be the regulators of CD8+ T cell-related marker genes for chronic brucellosis infections. The differentially expressed miRNAs and their predicted target genes are involved in MAPK signaling pathway, cytokine-cytokine receptor interactions, endocytosis, regulation of actin cytoskeleton, and focal adhesion indicating their potential roles in chronic brucellosis and its progression. It is the first study of miRNA expression analysis of human CD8+ T cells to clarify the mechanism of inveteracy in brucellosis.

Description

Keywords

Science & technology - other topics, T-lymphocytes, Up-regulation, Differential expression, Prostate-cancer, Down-regulation, Poor-prognosis, Serum mirnas, Hepatitis-B, Proliferation, Melitensis

Citation

Budak, F. vd. (2016). "MicroRNA expression patterns of CD8+ T cells in acute and chronic brucellosis". Plos One, 11(11).